Journal profile · IMMUNOLOGY
Immunopathologia Persa
ISSN 2423-8015 · Nickan Research Institute · Iran, Islamic Republic of
Immunopathologia Persa: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC charged, amount not published; median 90 days to acceptance (62 articles, last 24 months); 53 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Immunopathologia Persa is published by Nickan Research Institute and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19 and SARS-CoV-2 and COVID-19 Research, together about 31.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): IMMUNOLOGY
Editorial board by country: none in mainland China; most named Iran 20, United States 4 (24 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine16.6%
- Long-Term Effects of COVID-19Medicine7.9%
- SARS-CoV-2 and COVID-19 ResearchMedicine7.4%
- Liver Disease Diagnosis and TreatmentMedicine5.2%
- Renal Diseases and GlomerulopathiesMedicine4.8%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology4.4%
- Pregnancy and preeclampsia studiesMedicine4.4%
- Respiratory Support and MechanismsMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.23LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 17OpenAlex ·
- 2-year mean citedness
- 0.97OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 96.58%LetPub ·
Volume
- Articles per year
- 46LetPub ·
Articles by year OpenAlex count · 395 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 5 | 5 | 0 |
| 2025 | 53 | 53 | 46 |
| 2024 | 42 | 42 | 51 |
| 2023 | 41 | 41 | 50 |
| 2022 | 74 | 74 | 139 |
| 2021 | 57 | 57 | 206 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
90 daysMedian, submission to acceptance · P25–P75 69 days – 115 days
- Acceptance to online
- median 23 days (62 articles)
- Submission to online
- median 116 days
- Sample
- 62 articles with submission and acceptance dates (72 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 weeksLetPub ·
- Peer review
- Blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 8,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
Article types accepted18, with length limits
- case reportsThese reports should include introduction, case description, discussion and conclusions.Length not stated
- commentariesCommentaries present the author’s considered opinion (up to ~1000 words limited to one figure/table and limited references) on an original article to be publish…Length not stated
- commentaryluding tables, figures and references). Commentaries Commentaries present the author’s considered opinion (up to ~1000 words limited to one figure/table and lim…main text ≤ 1,000 words
- editorialThe following is the editorial workflow that every paper submitted to the Immunopathologia Persa will undergo during the course of the peer-review process. The …Length not stated
- epidemiology and preventionThis part is devoted mostly to epidemiology and prevention of treatment in the area of nephrology.Length not stated
- full original researchesA full length original research article (up to ~8000 words, including tables, figures and references) presents novel findings relevant to the aims and scope of …Length not stated
- hypothesisThis type of paper is related to an opinion or a hypothesis on a subject in the area of treatment in nephrology, kidney transplantation and hemodialysis. Hypoth…Length not stated
- letternsent should be obtained when possible. Letters to Editor Letter to Editor presents the author’s opinion (up to ~1000 words limited to one figure/table with lim…main text ≤ 1,000 words
- letters to editorLetter to Editor presents the author’s opinion (up to ~1000 words limited to one figure/table with limited references).Length not stated
- mini reviewand scope of the journal. Mini-Reviews Mini Reviews are sharply focused, well-focused, well-documented examinations of timely related issues (up to ~4000 words,…main text ≤ 4,000 words
- mini-reviewsMini Reviews are sharply focused, well-focused, well-documented examinations of timely related issues (up to ~4000 words, including tables, figures and referenc…Length not stated
- news and viewsNews and views are devoted mostly to recent findings of treatment in nephrology and renal transplantation, accompanied by the views of the authors.Length not stated
- original research articleFull Original Researches A full length original research article (up to ~8000 words, including tables, figures and references) presents novel fmain text ≤ 8,000 words
- photo-clinicIn this section, an interesting photo in the field of nephrology provided a brief description and a few references (up to five).Length not stated
- reviewt to the aims and scope of the journal. Reviews A full length critical review (up to ~8000 words, including tables, figures and references) provides an abstmain text ≤ 8,000 words
- reviewsA full length critical review (up to ~8000 words, including tables, figures and references) provides an abstract and discussion of the relevant literature about…Length not stated
- short communicationan those typically covered in a review. Short Communications Short Communications are preliminary reports (up to ~2000 words, including tables, figures and refe…main text ≤ 2,000 words · abstract ≤ 200 words
- short communicationsShort Communications are preliminary reports (up to ~2000 words, including tables, figures and references).Length not stated
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, Peer review
- Conflicts of interest Conflicts of Interest
The authors must declare any conflict of interests of contributed authors very briefly in a separate paragraph at the end of the paper. All sources of funding should be declared; unless otherwise the following sentence should be given “Authors declare no conflict of interests”.
Source ↗Publisher website ·- Publication ethics
Follows ICMJE, COPE, WAME guidelines. Model summary
ImmunopathologiaPersa follows ICMJE's Uniform Requirements for Manuscripts Submitted to Biomedical Journals and Committee on Publication Ethics (COPE), as well as, World Association of Medical Editors (WAME) for manuscripts submitted to Biomedical Journals.
Source ↗Publisher website ·- Peer review Peer-Review Policy
21-day rapid review process. Model summary
The Journal of Immunopathologia Persa performs an exact peer-review process to verify the strength of the study and confirm the scientific precision of the manuscripts. All papers will assign to the editorial review. Independent peer-reviewers with related knowledge of the submitted papers assess the papers to support editors to define the validity of a manuscript for publication in this journal. …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Nickan Research Institute
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2423-8015
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Immunopathologia Persa
What CAS zone is Immunopathologia Persa in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunopathologia Persa is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Immunopathologia Persa?
Based on the dates recorded on 62 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 69–115 days); authors report an average review time of about 3 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Immunopathologia Persa?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 8,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Immunopathologia Persa based?
Of the 24 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (20) and United States (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunopathologia Persa?
According to LetPub and DOAJ records, Immunopathologia Persa is indexed in ESCI and Scopus.
Is Immunopathologia Persa open access, and what is the APC?
Immunopathologia Persa is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .